Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,366.85
    +247.92 (+0.37%)
     

  • CMC Crypto 200

    1,432.72
    +8.62 (+0.61%)
     

  • FTSE 100

    8,091.87
    +47.06 (+0.58%)
     

  • Gold

    2,330.70
    -11.40 (-0.49%)
     

  • Crude Oil

    83.01
    -0.35 (-0.42%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Are Illumina and Beam Therapeutics the Healthcare Industry's Rising Stars?

Keith Speights and Brian Orelli, PhD, The Motley Fool
·2-min read

In this Motley Fool Live video recorded on Jan. 12, 2022, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not the two companies are rising stars in healthcare. Keith Speights: Illumina, which we've talked about, and Beam Therapeutics, she says, "Are they rising stars, and what about other CRISPR stocks?" Are Illumina and Beam rising stars, Brian?

Continue reading